Science Explorer Back to mapMap
Discussion
Researcher · National Center for Geriatrics and Gerontology · Japan

Masataka Shibasaki

Masataka Shibasaki publishes mostly in Epidemiology, Infectious Diseases and Molecular Biology, on topics such as Heme Oxygenase-1 and Carbon Monoxide, Geriatric Care and Nursing Homes and Antimicrobial Resistance in Staphylococcus.

OpenAlex
World rank
#5,017,015
of 7,710,434 ranked researchers
Rank in Japan
#158,119
of 383,136
Works
19
Citations
244
Citations per work
12.8
h-index
6
i10-index 6Top 82% in Epidemiology
Masataka Shibasaki

What does Masataka Shibasaki research?

Masataka Shibasaki's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (9%), Immunology and Microbiology (9%).

Health Sciences: 9 works · 45.5% of their workMedicine: 7 works · 36.4% of their workEpidemiology: 3 works · 18.2% of their workInfectious Diseases: 2 works · 9.1% of their workPharmacology: 2 works · 9.1% of their workHealth Professions: 2 works · 9.1% of their workGeneral Health Professions: 2 works · 9.1% of their workEverything else: 7 works · 36.3% of their workLife Sciences: 3 works · 18.2% of their workBiochemistry, Genetics and Molecular Biology: 2 works · 9.1% of their workMolecular Biology: 2 works · 9.1% of their workImmunology and Microbiology: 2 works · 9.1% of their workImmunology: 2 works · 9.1% of their workTHEIR WORKMasatakaShibasaki19works
Life Sciences18%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine736.4%
    2. Health Professions29.1%
  2. Everything else736.3%
    1. Biochemistry, Genetics and Molecular Biology29.1%
    2. Immunology and Microbiology29.1%
  1. 1Epidemiology18% of their works
  2. 2Infectious Diseases9% of their works
  3. 3Molecular Biology9% of their works
  4. 4Immunology9% of their works
  5. 5Pharmacology9% of their works
  6. 6General Health Professions9% of their works

Research topics

Which keywords describe Masataka Shibasaki's research?

The keywords of their largest research topics: Antimicrobial Resistance, Epidemiology, Healthcare-Associated Infections, Antibiotic Pharmacokinetics, Carbon Monoxide, Critically Ill Patients, End-of-Life and Heme Oxygenase-1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 19 words, with their numbers
  1. Antimicrobial Resistance83 topics
  2. Epidemiology73 topics
  3. Healthcare-Associated Infections52 topics
  4. Antibiotic Pharmacokinetics31 topic
  5. Carbon Monoxide31 topic
  6. Critically Ill Patients31 topic
  7. End-of-Life31 topic
  8. Heme Oxygenase-131 topic
  9. MRSA31 topic
  10. Nursing Home31 topic
  11. Palliative Care31 topic
  12. Quality of Care31 topic
  13. Staphylococcus aureus31 topic
  14. Community-Acquired Pneumonia21 topic
  15. ICU21 topic
  16. Pneumococcal Conjugate Vaccine21 topic
  17. Pneumocystis21 topic
  18. Pneumonia21 topic
  19. Ventilator-associated Pneumonia21 topic

Where does Masataka Shibasaki work?

Masataka Shibasaki's main affiliation in the publication record is National Center for Geriatrics and Gerontology, Japan.

How many publications and citations does Masataka Shibasaki have?

OpenAlex counts 19 works and 244 citations for Masataka Shibasaki, an h-index of 6, ranking #5,017,015 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Masataka Shibasaki. Posts are plain text and can be reported.